Biocartis

Claim instruction:

Send us an email to claim@startus.cc from an official Biocartis email account. The content must be:

StartUs buddies,

Please, allow me to claim rights over Biocartis.

Best regards,
[your name]
Once sent the email click the Claim Startup button.
Our team will verify the origin account and will grant claim rights over the startup to the user if everything is ok.

https://www.startus.cc/company/biocartis

Generaal De Wittelaan 11

B3 2800 Mechelen

Belgium

Website

https://www.facebook.com/Biocartis-484220648286615/timeline/

https://twitter.com/Biocartis_

General information:

Biocartis aims to improve quality of life by enabling direct access to personalized medicine to patients worldwide. Its goal is to advance medical treatment through the broad implementation of state-of-the-art diagnostic tests performed close to the clinical decision-making point.

Biocartis' innovative research and diagnostic systems feature the detection of molecular components, which are indicative for a specific pathological state. The new systems are highly user-friendly, require less hands-on time and minimize the handling of valuable samples, which is of the utmost importance for tumor biopsies. In addition, Biocartis develops assays with major clinical and compelling health economic value. Oncology is Biocartis' primary focus as it represents one of the areas with the highest unmet needs for personalized medicine.

Biocartis is a rapidly growing company that currently employs close to 200 people. It has offices in Belgium (close to Brussels) and in Switzerland (Lausanne).

Company information:

Company type:

Startup

Industry:

Healthcare / Medical Services

Products and Services:

Idylla™

Product category:

Medical devices

Idylla™, Biocartis’ fully automated, real-time PCR based molecular diagnostics system, is designed to offer fast and easy access to clinical molecular diagnostic information, anywhere and anytime. The Idylla™ platform covers the entire process from sample to result in a time frame of 35 to 150 minutes with less than 2 minutes hands-on time. Idylla™ is applicable for a wide range of clinical sample types and can analyze both RNA and DNA. The fully integrated system enables clinical laboratories to perform a broad range of applications in oncology, infectious diseases and beyond.

Idylla™, Idylla™ KRAS Mutation Test and Idylla™ BRAF Mutation Test are CE-marked IVDs. Biocartis’ trademark and logo are registered in Europe.